 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19482
Article Published : 8050
Total Authors : 21282
Total Reviewer : 770
Total Countries : 145
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Medication Over Use Headache: Characteristic, Etiopathophysiology, Diagnosis and Emerging Treatment |
| Authors Name: | SHAH RAJVI , KALOLA RINKAL , SONI KANAL , AARZOO SHARMA , NIMISHA PATEL |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_187581
|
| Published Paper Id: | IJRTI2307055 |
| Published In: | Volume 8 Issue 7, July-2023 |
| DOI: | |
| Abstract: | Background: Medication overuse headache (MOH), formerly known as drug-induced headache, which affects 1% of people worldwide, constitutes one of the most debilitating headache conditions. However, it's entirely different, the use of acute symptomatic medications for 10–15 days in a month (depending on the drug class, such as simple analgesics, triptans, and opioids) and the use of these medications for headache relief for three months or more in patients having a history of primary headache disorders. Objective: With an emphasis on recent developments in the fields of pathophysiology, risk factors, clinical features, and treatment, the purpose of this article was to examine the subject of MOH and provide the specifics of this condition. Material and methods: For the purpose of writing this review, a search of the literature was conducted using appropriate keywords in the PubMed/MEDLINE and Springer databases. We reviewed around 71 articles by using keyword like “MOH”, “pathophysiology of MOH”, ”risk factors of MOH”, “CGRP”. Boolean operators “AND" and "OR" were employed. Results: The idea of MOH has changed over time, despite one occurrence of grey matter disturbances, the distinct pathogenesis is still being contemplated. Modification in pain pathways, changes in areas of the brain associated with pain intensity, and neurotransmitter changes have all been related to genetic vulnerability. A detailed medical history is required to separate it from other secondary recurring daily headache disorders, focused testing, and information on medication usage. The most common forms of treatment for primary headache disorders in outpatient or inpatient settings include patient disease information, abstinence of the causative agent, and management through preventive medications are all approaches. Conclusions: Any person with a chronic headache should be evaluated for MOH, a secondary headache disease. Its development is linked to a number of pathophysiological pathways and risk factors. Detoxification, preventive therapy, and education on the disorder are all part of management |
| Keywords: | migraine, medication overuse headache, headache disorder, triptans |
| Cite Article: | "Medication Over Use Headache: Characteristic, Etiopathophysiology, Diagnosis and Emerging Treatment", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 7, page no.362 - 370, July-2023, Available :http://www.ijrti.org/papers/IJRTI2307055.pdf |
| Downloads: | 000205159 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2307055
Registration ID:187581
Published In: Volume 8 Issue 7, July-2023
DOI (Digital Object Identifier):
Page No: 362 - 370 Country: Gandhinagar, Gujrat, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2307055 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2307055 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||